Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$34.8M |
| 2 |
Kinder Morgan
KMI
|
+$27.8M |
| 3 |
EOG Resources
EOG
|
+$27.5M |
| 4 |
Medtronic
MDT
|
+$27.1M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$42.7M |
| 2 |
Apple
AAPL
|
+$36.5M |
| 3 |
Comcast
CMCSA
|
+$33.5M |
| 4 |
CVS Health
CVS
|
+$30.9M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$29.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.53% |
| 2 | Technology | 15.96% |
| 3 | Consumer Discretionary | 14.59% |
| 4 | Healthcare | 13.04% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Franco-Nevada
FNV
$51.3B
| $1.24M | 0.03% |
+12,434
| New | +$1.35M |
|
502
Core Laboratories
CLB
$574M
| $1.23M | 0.03% |
119,286
+91,348
| +327% | +$2.55M |
|
503
Sonoco
SON
$5.88B
| $1.23M | 0.03% |
26,561
+6,857
| +35% | +$366K |
|
504
Gartner
IT
$12.4B
| $1.22M | 0.03% |
+12,282
| New | +$1.68M |
|
505
Timken Company
TKR
$8.67B
| $1.22M | 0.03% |
37,830
-56,447
| -60% | -$2.67M |
|
506
Middleby
MIDD
$5.22B
| $1.22M | 0.03% |
+21,398
| New | +$2.1M |
|
507
NextEra Energy
NEE
$174B
| $1.21M | 0.03% |
20,156
+13,804
| +217% | +$868K |
|
|
ODP
508
DELISTED
ODP
ODP
| $1.2M | 0.03% |
73,275
+50,411
| +220% | +$1.13M |
|
509
Woodward
WWD
$20.3B
| $1.2M | 0.03% |
20,189
+13,040
| +182% | +$1.35M |
|
|
EA
510
DELISTED
Electronic Arts
EA
| $1.19M | 0.03% |
11,919
-94
| -0.8% | -$9.89K |
|
511
Deere & Co
DE
$175B
| $1.19M | 0.03% |
8,612
-433
| -5% | -$68.5K |
|
512
Adient
ADNT
$1.54B
| $1.19M | 0.03% |
130,834
+112,026
| +596% | +$2.26M |
|
513
DMC Global
BOOM
$144M
| $1.19M | 0.03% |
51,583
+15,620
| +43% | +$562K |
|
514
Laureate Education
LAUR
$5.16B
| $1.19M | 0.03% |
112,815
-24,659
| -18% | -$427K |
|
|
TWNK
515
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.17M | 0.03% |
109,914
+32,863
| +43% | +$417K |
|
|
EGRX
516
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.16M | 0.03% |
25,300
-11,290
| -31% | -$567K |
|
517
JetBlue
JBLU
$1.85B
| $1.16M | 0.03% |
129,115
-307,294
| -70% | -$5.09M |
|
|
BIG
518
DELISTED
Big Lots, Inc.
BIG
| $1.14M | 0.03% |
80,006
-10,380
| -11% | -$235K |
|
|
GMS
519
DELISTED
GMS Inc
GMS
| $1.14M | 0.03% |
72,130
-39,722
| -36% | -$941K |
|
520
Fortinet
FTNT
$113B
| $1.13M | 0.03% |
56,060
-7,235
| -11% | -$155K |
|
521
e.l.f. Beauty
ELF
$6.02B
| $1.13M | 0.03% |
114,289
+53,299
| +87% | +$800K |
|
522
Progress Software
PRGS
$1.82B
| $1.12M | 0.03% |
35,053
-12,536
| -26% | -$505K |
|
523
Innoviva
INVA
$1.52B
| $1.12M | 0.03% |
95,270
-11,664
| -11% | -$154K |
|
524
CME Group
CME
$98.9B
| $1.11M | 0.03% |
6,414
+3,923
| +157% | +$781K |
|
525
Buckle
BKE
$2.26B
| $1.11M | 0.03% |
80,786
+60,731
| +303% | +$1.37M |
|
Similar funds
Joel Greenblatt's Q1 2020 Portfolio in Review
As of Q1 2020, Joel Greenblatt held 1,293 positions worth $3.6B, down 34% from $5.45B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Joel Greenblatt withdrew a net $266M in Q1 2020, closing 238 positions and reducing 416 holdings. Its most notable exit was Johnson Controls International, an estimated $28.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in CONCHO RESOURCES INC. worth $16.6M.
- Joel Greenblatt's largest Q1 2020 buy was CONCHO RESOURCES INC.: 388,298 shares worth $16.6M.
- Joel Greenblatt added most to TJX Companies in Q1 2020, an estimated $34.8M increase.
- Joel Greenblatt's biggest Q1 2020 reduction was Bristol-Myers Squibb, cutting an estimated $42.7M.
- Joel Greenblatt fully exited Johnson Controls International in Q1 2020, selling an estimated $28.1M.
- Joel Greenblatt's ten largest holdings make up 9.7% of its $3.6B portfolio in Q1 2020.
- Joel Greenblatt opened 206 new positions and closed 238 in Q1 2020.
- Joel Greenblatt's portfolio value fell 34% quarter-over-quarter to $3.6B.
Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.